Logo 4358 300 Pill - beige oval, 16mm
Pill with imprint Logo 4358 300 is Beige, Oval and has been identified as Ranitidine Hydrochloride 300 mg. It is supplied by Teva Pharmaceuticals USA.
Ranitidine is used in the treatment of GERD; Erosive Esophagitis; Gastric Ulcer Maintenance Treatment; Cutaneous Mastocytosis; Duodenal Ulcer and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Logo 4358 300
Ranitidine Hydrochloride
- Imprint
- Logo 4358 300
- Strength
- 300 mg
- Color
- Beige
- Size
- 16.00 mm
- Shape
- Oval
- Availability
- Rx and/or OTC
- Drug Class
- H2 antagonists
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA
- National Drug Code (NDC)
- 00172-4358 (Discontinued)
- Inactive Ingredients
-
croscarmellose sodium,
hypromelloses,
lactose monohydrate,
magnesium stearate,
microcrystalline cellulose,
ferric oxide red,
titanium dioxide,
triethyl citrate,
ferric oxide yellow
Note: Inactive ingredients may vary.
More about ranitidine
- Check interactions
- Compare alternatives
- Reviews (163)
- Drug images
- Latest FDA alerts (18)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Drug class: H2 antagonists
- Breastfeeding
Patient resources
Other brands
Professional resources
- Ranitidine prescribing information
- Ranitidine Capsule (FDA)
- Ranitidine Injection (FDA)
- Ranitidine Syrup (FDA)
- Ranitidine Tablets (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.